COVID vaccine: BioNTech plans 2 billion doses this year

The German vaccine maker BioNTech and US pharmaceutical giant Pfizer said they could produce up to 2 billion doses of their coronavirus vaccine in 2021,according to documents released on Monday.

The new production goal is an increase on the previously planned 1.3 billion doses the partners had aimed for.

BioNTech said the higher production goal is based on improvements and enlargements at production facilities, and an increase in available suppliers and production partners, according to documents submitted to the US Securities and Exchange Commission (SEC).